Oncotelic Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch OTLC and buy or sell other stocks, ETFs, and their options commission-free!

About OTLC

Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. 

CEO
Vuong Trieu
CEOVuong Trieu
Employees
40
Employees40
Headquarters
Agoura Hills, California
HeadquartersAgoura Hills, California
Founded
1988
Founded1988
Employees
40
Employees40

OTLC Key Statistics

Market cap
39.58M
Market cap39.58M
Price-Earnings ratio
-9.38
Price-Earnings ratio-9.38
Dividend yield
—
Dividend yield—
Average volume
258.24K
Average volume258.24K
High today
$0.097
High today$0.097
Low today
$0.091
Low today$0.091
Open price
$0.0921
Open price$0.0921
Volume
40.00K
Volume40.00K
52 Week high
$0.11
52 Week high$0.11
52 Week low
$0.02
52 Week low$0.02
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.